AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25612789 — intervention group
Group type: COMPARATOR
Intervention: Conventional discharge strategy (CDS)
Number of subjects: 100
Study 23434915 — intervention group
Group type: EXPERIMENTAL
Intervention: Different examples of different textures
Number of subjects: 0
Study 23434915 — intervention group
Group type: EXPERIMENTAL
Intervention: Different examples of the same texture
Number of subjects: 0
Study 21208446 — intervention group
Group type: EXPERIMENTAL
Intervention: High Glycemic Index (HGI) meals
Number of subjects: 15
Study 21208446 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Glycemic Index (LGI) meals
Number of subjects: 15
Study 19565729 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at points of The Liver and Gallbladder Meridians
Number of subjects: 253
Study 19565729 — intervention group
Group type: COMPARATOR
Intervention: Western medicine group (Flunarizine tablets)
Number of subjects: 253
Study 19565729 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group
Number of subjects: 253
Study 17419283 — intervention group
Group type: COMPARATOR
Intervention: 250 mg clarithromycin (C250 group)
Number of subjects: 171
Study 17419283 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg clarithromycin and 500 mg vitamin C (V-C250 group)
Number of subjects: 171
Study 17419283 — intervention group
Group type: COMPARATOR
Intervention: 500 mg clarithromycin (C500 group)
Number of subjects: 171
Study 17419283 — intervention group
Group type: COMPARATOR
Intervention: All groups (C250, V-C250, C500)
Number of subjects: 171
Study 15671923 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-declared diabetic patients
Number of subjects: 67
Study 11157010 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin 60 mg/m² plus cyclophosphamide 600 mg/m² every 3 weeks (arm A)
Number of subjects: 150
Study 11157010 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone 23 mg/m² plus cyclophosphamide 600 mg/m² with filgrastim 5 µg/kg/d from days 2 to 15 every 3 weeks (arm B)
Number of subjects: 150
Study 11157010 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone 23 mg/m² plus cyclophosphamide with filgrastim (arm B)
Number of subjects: 150
Study 11157010 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin 60 mg/m² plus cyclophosphamide 600 mg/m² (arm A)
Number of subjects: 150
Study 9830317 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis patients
Number of subjects: 181
Study 9830317 — intervention group
Group type: EXPERIMENTAL
Intervention: Transplanted patients
Number of subjects: 181
Study 9830317 — intervention group
Group type: COMPARATOR
Intervention: Control group (general population)
Number of subjects: 181
Study 8005064 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined chemo- and radiotherapy without preceding operation
Number of subjects: 23
Study 8005064 — intervention group
Group type: COMPARATOR
Intervention: Surgical resection followed by chemo- and/or radiotherapy
Number of subjects: 23
Study 2920548 — intervention group
Group type: EXPERIMENTAL
Intervention: Benztropine
Number of subjects: 12
Study 2920548 — intervention group
Group type: COMPARATOR
Intervention: Glycopyrrolate (active placebo)
Number of subjects: 12
Study 31424391 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported SMCs measured with the Prospective and Retrospective Memory Questionnaire (PRMQ)
Number of subjects: 303
Study 31424391 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported retrospective memory problems
Number of subjects: 303
Study 31424391 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported prospective memory problems
Number of subjects: 303
Study 31424391 — intervention group
Group type: EXPERIMENTAL
Intervention: Informant-reported memory problems
Number of subjects: 303
Study 29326333 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease management intervention (self‐management programme, home telemonitoring, care coordination, medical management)
Number of subjects: 319
Study 29326333 — intervention group
Group type: COMPARATOR
Intervention: Usual management practices
Number of subjects: 319
Study 29326333 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease management intervention
Number of subjects: 319
Study 26508701 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogens (0.45 mg/day) with progesterone (200 mg/day for 12 days each month)
Number of subjects: 606
Study 26508701 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17β‐estradiol (50 μg/day) with progesterone (200 mg/day for 12 days each month)
Number of subjects: 606
Study 26508701 — intervention group
Group type: COMPARATOR
Intervention: Placebo pills and patch
Number of subjects: 606
Study 25386086 — intervention group
Group type: EXPERIMENTAL
Intervention: Splenic artery banding (n=28)
Number of subjects: 43
Study 25386086 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=15)
Number of subjects: 43
Study 25386086 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary blockade of the splenic artery
Number of subjects: 43
Study 22564540 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiparametric MRI examination followed by a second TRUS-guided prostate biopsy
Number of subjects: 180
Study 22564540 — intervention group
Group type: COMPARATOR
Intervention: Second random TRUS-guided prostate biopsy
Number of subjects: 180
Study 20150839 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 56
Study 20150839 — intervention group
Group type: COMPARATOR
Intervention: No statin treatment
Number of subjects: 56
Study 18577956 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine 20 mg/d
Number of subjects: 23
Study 18577956 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 23
Study 15626966 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck exercise program with activation of deep neck muscles and dynamic strengthening for 6 weeks
Number of subjects: 145
Study 15626966 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck exercise program
Number of subjects: 145
Study 15626966 — intervention group
Group type: COMPARATOR
Intervention: Control group (infrared irradiation and neck care advice)
Number of subjects: 145
Study 11384572 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (100 mg)
Number of subjects: 15
Study 11384572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9223203 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion of 0.25% bupivacaine (group C, n = 10)
Number of subjects: 20
Study 9223203 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hourly bolus of 0.25% bupivacaine (group B, n = 10)
Number of subjects: 20
Study 8124207 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg bd)
Number of subjects: 92
Study 8124207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 8124207 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 92
Study 3303813 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (up to 30 mIU/min)
Number of subjects: 100
Study 3303813 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose prostaglandin F2 alpha (PGF2 alpha, up to 6.0 micrograms/min)
Number of subjects: 100
Study 3303813 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 100
Study 3303813 — intervention group
Group type: COMPARATOR
Intervention: Low-dose prostaglandin F2 alpha (PGF2 alpha)
Number of subjects: 100
Study 2809851 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic crown systems (Cerestore, Dicor, Hi‐Ceram, Renaissance, Vitadur‐N)
Number of subjects: 25
Study 2809851 — intervention group
Group type: EXPERIMENTAL
Intervention: Coloured luting agents
Number of subjects: 25
Study 31801600 — intervention group
Group type: EXPERIMENTAL
Intervention: Fire acupuncture
Number of subjects: 120
Study 31801600 — intervention group
Group type: COMPARATOR
Intervention: General acupuncture
Number of subjects: 120
Study 27028190 — intervention group
Group type: EXPERIMENTAL
Intervention: tamsulosin 0.2 mg plus solifenacin 5 mg (Group II)
Number of subjects: 146
Study 27028190 — intervention group
Group type: EXPERIMENTAL
Intervention: tamsulosin 0.2 mg plus solifenacin 10 mg (Group III)
Number of subjects: 146
Study 27028190 — intervention group
Group type: COMPARATOR
Intervention: tamsulosin 0.2 mg (Group I)
Number of subjects: 146
Study 26075840 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 1432
Study 26075840 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 1432
Study 26075840 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 1432
Study 26075840 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 1432
Study 26075840 — intervention group
Group type: EXPERIMENTAL
Intervention: Perphenazine (first-generation antipsychotic)
Number of subjects: 1432
Study 23805979 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 3 months
Number of subjects: 21
Study 23805979 — intervention group
Group type: COMPARATOR
Intervention: Non-trained CHF patients (CHF-C group)
Number of subjects: 21
Study 20953959 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary BMC
Number of subjects: 78
Study 20953959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 19221919 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-guided web-based cognitive behavioural treatment (web-CBT)
Number of subjects: 54
Study 16916668 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (4 microg.kg(‐1).h(‐1))
Number of subjects: 20
Study 16916668 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.4 mg.kg(‐1).h(‐1))
Number of subjects: 20
Study 15770968 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior dynamic imaging
Number of subjects: 68
Study 15770968 — intervention group
Group type: COMPARATOR
Intervention: Anterior dynamic imaging
Number of subjects: 68
Study 11294076 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial interventions
Number of subjects: 0
Study 9610217 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic outcome - Life satisfaction
Number of subjects: 435
Study 9610217 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic health
Number of subjects: 435
Study 9610217 — intervention group
Group type: EXPERIMENTAL
Intervention: Incontinence-specific QoL outcomes
Number of subjects: 435
Study 7936339 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopexamine infusion at a dose of 1 microgram/kg/m during aortic cross-clamping and 0.5 micrograms/kg/m from declamping to the end of surgery
Number of subjects: 25
Study 7936339 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopexamine infusion
Number of subjects: 25
Study 7936339 — intervention group
Group type: COMPARATOR
Intervention: No dopexamine infusion (Control Group I)
Number of subjects: 25
Study 3354934 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic external defibrillators used to defibrillate and record patient rhythms
Number of subjects: 36
Study 3354934 — intervention group
Group type: COMPARATOR
Intervention: Control group with automatic external defibrillators used only to record
Number of subjects: 36
Study 29998356 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy applied on the right side
Number of subjects: 62
Study 29998356 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied on the right side
Number of subjects: 62
Study 29998356 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy applied on the left side
Number of subjects: 62
Study 29998356 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied on the left side
Number of subjects: 62
Study 29998356 — intervention group
Group type: COMPARATOR
Intervention: Gender comparison in placebo group
Number of subjects: 62
Study 29998356 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender comparison in laser group after 48 hours
Number of subjects: 62
Study 28851276 — intervention group
Group type: EXPERIMENTAL
Intervention: Horticultural therapy (HT)
Number of subjects: 70
Study 28851276 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 70
Study 25358119 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet support intervention
Number of subjects: 414
Study 25358119 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 414
Study 22372531 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (30 mg)
Number of subjects: 21
Study 22372531 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (60 mg)
Number of subjects: 21
Study 22372531 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (600 mg)
Number of subjects: 21
Study 21171738 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Motivational (SM) orientation + Parent-Child Interaction Therapy (PCIT)
Number of subjects: 192
Study 21171738 — intervention group
Group type: COMPARATOR
Intervention: Self-Motivational (SM) orientation
Number of subjects: 192
Study 21171738 — intervention group
Group type: COMPARATOR
Intervention: Parent-Child Interaction Therapy (PCIT)
Number of subjects: 192
Study 21171738 — intervention group
Group type: COMPARATOR
Intervention: Services as Usual (SAU)
Number of subjects: 192
Study 19894381 — intervention group
Group type: EXPERIMENTAL
Intervention: SXDZ-100 Nerve and Muscle Stimulator
Number of subjects: 87
Study 19894381 — intervention group
Group type: COMPARATOR
Intervention: G6805 Electric Stimulator
Number of subjects: 87
Study 18386606 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimebutine 100 mg t.i.d.
Number of subjects: 50
Study 18386606 — intervention group
Group type: COMPARATOR
Intervention: Placebo t.i.d.
Number of subjects: 50
Study 12492804 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 4 micro g kg‐1 in apple juice 0.2 ml kg‐1
Number of subjects: 80
Study 12492804 — intervention group
Group type: COMPARATOR
Intervention: Apple juice 0.2 ml kg‐1 (Control)
Number of subjects: 80
Study 11270321 — intervention group
Group type: EXPERIMENTAL
Intervention: (‐)‐R‐clevidipine
Number of subjects: 20
Study 11270321 — intervention group
Group type: EXPERIMENTAL
Intervention: (+)‐S‐clevidipine
Number of subjects: 20
Study 11270321 — intervention group
Group type: COMPARATOR
Intervention: Racemic clevidipine
Number of subjects: 20
Study 9594559 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CAD or HT
Number of subjects: 148
Study 9594559 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 148
Study 9594559 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 148
Study 9594559 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic dysfunction ratio (DDR)
Number of subjects: 148
Study 8319552 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 1-s vibroacoustic stimulus (VAS) delivered after 3-5 min of quiet sleep (QS), Group II, N = 33
Number of subjects: 96
Study 8319552 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 1-s vibroacoustic stimulus (VAS) delivered after 18-20 min of quiet sleep (QS), Group III, N = 31
Number of subjects: 96
Study 8319552 — intervention group
Group type: COMPARATOR
Intervention: No stimulation, Group I, N = 32
Number of subjects: 96
Study 2967184 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg once daily
Number of subjects: 19
Study 2967184 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol 10 mg once daily
Number of subjects: 19
Study 2967184 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 100 mg once daily
Number of subjects: 19
Study 2967184 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments (Bisoprolol 5 mg, Bisoprolol 10 mg, Atenolol 100 mg)
Number of subjects: 19
Study 29957829 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet alone
Number of subjects: 140
Study 29957829 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet + resistance training
Number of subjects: 140
Study 29957829 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet + aerobic training
Number of subjects: 140
Study 27410392 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised nutritional care by a dietitian, including prescription of wound healing supplements
Number of subjects: 50
Study 27410392 — intervention group
Group type: COMPARATOR
Intervention: Standard nutritional care
Number of subjects: 50
Study 25414095 — intervention group
Group type: EXPERIMENTAL
Intervention: Books Beyond Words booklet plus usual care
Number of subjects: 40
Study 25414095 — intervention group
Group type: COMPARATOR
Intervention: Routine information and services (control group)
Number of subjects: 40
Study 22322195 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip (IHG) training (four, 2‐min sustained contractions at 30% of maximal voluntary contraction, three times per week for 8‐10 weeks)
Number of subjects: 20
Study 22322195 — intervention group
Group type: COMPARATOR
Intervention: Control group (medicated hypertensive patients)
Number of subjects: 20
Study 19800680 — intervention group
Group type: EXPERIMENTAL
Intervention: T suis ova (2500 live ova, 8 doses, 21-day interval)
Number of subjects: 100
Study 19800680 — intervention group
Group type: EXPERIMENTAL
Intervention: T suis ova
Number of subjects: 100
Study 17273038 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal-dome osteotomy
Number of subjects: 27
Study 17273038 — intervention group
Group type: COMPARATOR
Intervention: Straight-cut osteotomy
Number of subjects: 27
Study 16143578 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubating laryngeal mask in right lateral position
Number of subjects: 82
Study 16143578 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubating laryngeal mask in left lateral position
Number of subjects: 82
Study 16143578 — intervention group
Group type: COMPARATOR
Intervention: Intubating laryngeal mask
Number of subjects: 82
Study 12172716 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I: 50-ml mixture of 20 ml 0.5% bupivacaine hydrochloride, 10 ml 2% lidocaine hydrochloride, and 20 ml 0.9% sodium chloride; knee joint injected with 40 ml of the mixture; portal sites injected with 10 ml of the mixture.
Number of subjects: 130
Study 12172716 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II: Same mixture as Group I with 250 micro g epinephrine added; knee joint injected with 40 ml of the mixture; portal sites injected with 10 ml of the mixture.
Number of subjects: 130
Study 12172716 — intervention group
Group type: EXPERIMENTAL
Intervention: Group III: Same mixture as Group I with 50 micro g epinephrine added to 10 ml of the mixture for portal site injections; knee joint injected with 40 ml of the mixture.
Number of subjects: 130
Study 9526147 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectancy challenge targeting arousal
Number of subjects: 54
Study 9526147 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectancy challenge targeting sociability
Number of subjects: 54
Study 9526147 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 54
Study 8578174 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of recombinant interferon-alpha-2b (3 MIU, 3/7 days)
Number of subjects: 74
Study 8578174 — intervention group
Group type: COMPARATOR
Intervention: Low dose of recombinant interferon-alpha-2b (1 MIU, 3/7 days)
Number of subjects: 74
Study 2533669 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestrogen‐progestogen combinations
Number of subjects: 0
Study 2533669 — intervention group
Group type: COMPARATOR
Intervention: Pure progestagen
Number of subjects: 0
Study 347229 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release procainamide (PAD)
Number of subjects: 7
Study 30599885 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT)
Number of subjects: 20
Study 30599885 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 20
Study 27910283 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 1546
Study 27910283 — intervention group
Group type: COMPARATOR
Intervention: Corn-soy blends (CSB)
Number of subjects: 1546
Study 27092789 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg once a day for 12 weeks
Number of subjects: 80
Study 27092789 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg once a day for 12 weeks
Number of subjects: 80
Study 24687847 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored education-coaching intervention
Number of subjects: 135
Study 24687847 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 135
Study 22288493 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily reports tapping experienced or experienced and witnessed negative events
Number of subjects: 215
Study 22288493 — intervention group
Group type: COMPARATOR
Intervention: No daily reports
Number of subjects: 215
Study 19844656 — intervention group
Group type: COMPARATOR
Intervention: Disc arthroplasty
Number of subjects: 0
Study 19844656 — intervention group
Group type: COMPARATOR
Intervention: Spinal fusion
Number of subjects: 0
Study 18448748 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing maximal vaginal descent
Number of subjects: 260
Study 18448748 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing apical descent (POP-Q point C)
Number of subjects: 260
Study 18448748 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing anterior descent (POP-Q point Ba)
Number of subjects: 260
Study 18448748 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing posterior descent (POP-Q point Bp)
Number of subjects: 260
Study 16128472 — intervention group
Group type: EXPERIMENTAL
Intervention: Four firefighter extraction team with accompanying nurse and respiratory therapist
Number of subjects: 12
Study 16128472 — intervention group
Group type: COMPARATOR
Intervention: Four member teams
Number of subjects: 12
Study 16128472 — intervention group
Group type: EXPERIMENTAL
Intervention: Three member teams
Number of subjects: 12
Study 16128472 — intervention group
Group type: EXPERIMENTAL
Intervention: Firefighters' subjective evaluation
Number of subjects: 12
Study 16128472 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall performance evaluations
Number of subjects: 12
Study 16128472 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean extraction time
Number of subjects: 12
Study 11753127 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive therapies using thermal energy to ablate prostatic tissue
Number of subjects: 0